Effect of diclofenac as a prophylactic analgesic during hysterosalpingography in Bayelsa State, South-South Nigeria: a randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202203544008183

Enrollment

380

Registered

2022-03-25

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

Group I

Group II

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Infertile women referred for hysterosalpingography, and women that gave consent and completely filled the consent/questionnaire form will be included in the study

Exclusion criteria

Exclusion criteria: Exclusion criteria included abnormal uterine/vaginal bleeding before the procedure, on-going menstruation, pregnancy, discharge on inspection of the cervix, cervical stenosis/cervical pathology, evidence of pelvic inflammatory disease, previous history of contrast hypersensitivity, history of allergy to diclofenac, and all patients that declined consent or incompletely filled the consent form and questionnaire.

Design outcomes

Primary

Measure	Time frame
The primary outcomes include pain scores during and immediately after the procedure.	—

Secondary

Measure	Time frame
The secondary outcomes include differences in pain scores, and presence of any adverse effect in any of the groups.	—

Countries

Nigeria

Contacts

Public ContactEnefia Kelvin Kiridi

Consultant Radiologist Niger Delta University Teaching Hospital Okolobiri

kiridienefia@gmail.com+2348037249828

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026